* Clover Health Investments Corp reported a quarterly adjusted loss of 2 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -9 cents. The mean expectation of three analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -5 cents to -3 cents per share.
* Revenue fell 31.3% to $330.99 million from a year ago; analysts expected $346.28 million.
* Clover Health Investments Corp's reported EPS for the quarter was a loss of 2 cents.
* The company reported a quarterly loss of $9.16 million.
* Clover Health Investments Corp shares had risen by 54.3% this quarter and gained 356.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 11.1% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the managed healthcare peer group is also "hold"
Wall Street's median 12-month price target for Clover Health Investments Corp is $3.60 This summary was machine generated from LSEG data November 7 at 02:58 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.04 -0.02 Beat
Jun. 30 2024 -0.05 0.01 Beat
Mar. 31 2024 -0.07 -0.04 Beat
Dec. 31 2023 -0.14 -0.14 Met
Comments